In fact, amplification of the SETD1A gene in a high fraction (24%) of patient-derived breast cancer clones engrafting in mice could be attributed to the mitotic and cell cycle competence acquired by these high SETD1A expressing tumor cells21. The gene discussed is SETD1A; the disease is breast cancer.